<DOC>
	<DOCNO>NCT02335255</DOCNO>
	<brief_summary>To compare efficacy safety test formulation Naftifine Hydrochloride Gel 2 % Naftin® ( Naftifine Hydrochloride ) Gel 2 %</brief_summary>
	<brief_title>Evaluate Safety Efficacy Naftifine Hydrochloride Gel 2 % Naftin® Gel 2 % Tinea Pedis</brief_title>
	<detailed_description>The purpose study compare efficacy safety test formulation Naftifine Hydrochloride Gel 2 % Naftin® ( Naftifine Hydrochloride ) Gel 2 % six week study ( four week end two week treatment ) patient tinea pedis .</detailed_description>
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Naftifine</mesh_term>
	<criteria>Male nonpregnant , nonlactating female 18 year age old . The sum clinical sign symptom score target lesion least 4 , include minimum score least 2 erythema minimum score 2 either scale pruritus . Clinical diagnosis interdigital tinea pedis lesion localize interdigital space predominantly interdigital , may extend area foot . The presence interdigital tinea pedis infection , confirm observation segment fungal hypha microscopic potassium hydroxide wet mount preparation . Females pregnant , lactate plan become pregnant study period . Use antipruritic , include antihistamine within 72 hour prior baseline visit . Use topical corticosteroid , antibiotic antifungal therapy within 2 week prior baseline visit . Use systemic corticosteroid , antibiotic antifungal therapy within 1 month prior baseline visit . Use oral Terbinafine Itraconazole within 2 month prior baseline visit . Use immunosuppressive medication radiation therapy within 3 month prior baseline visit . Any known hypersensitivity Naftifine Hydrochloride , component formulation . Confluent , diffuse moccasintype tinea pedis entire plantar surface . History significant current evidence chronic infectious disease , system disorder , organ disorder , medical condition would place patient undue risk participation could jeopardize integrity study evaluation . Evidence concurrent dermatophytic infection toe nail dermatological condition foot may interfere investigator 's evaluation tinea pedis . Patients past history dermatophyte infection lack response antifungal therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>